WeGuide is thrilled to announce a groundbreaking funding milestone, having raised 129,000,000 to accelerate our mission of revolutionizing digital health engagement. With over 10 years of experience in digital healthcare and a well-established track record in delivering regulatory approved solutions, our self-service platform stands at the forefront of patient engagement innovation. The significant funds secured will be dedicated to further refining our WeGuide platform鈥攁 tool designed to empower healthcare providers, researchers, and clinical trial sponsors to effortlessly create bespoke patient engagement applications. By leveraging our expertise, clients can enhance therapy adherence, improve data quality, and drive better health outcomes through a reliable digital companion.
Our unique journey has been largely shaped by real-world success stories. Notably, our platform played a pivotal role in a global WHO Covid decentralised trial, engaging over 7,000 health professionals from the USA, UK, Netherlands, Brazil, and Australia. This demonstration of global adaptability and effectiveness underscores WeGuide鈥檚 capacity to address complex, multifaceted healthcare challenges at scale. With this new investment, we are poised to expand our capabilities, refine our technology, and extend our support, enabling organizations to seamlessly run decentralized clinical trials, collect real world evidence (RWE), and build digital companions tailored to unique devices or drugs.
As a proud spin off of the award-winning digital health agency Curve Tomorrow, WeGuide continues to build on its legacy of innovation and excellence. We invite potential partners and clients to connect with us if they wish to elevate their patient engagement strategies and transform their healthcare research into more effective, accessible, and patient-centered solutions.
